Carrie Powers

Chief Executive Officer at Reprise Biomedical.

Earliest Form D on file: May 2026

2 filings at 1 company

Reprise Biomedical

Biotech, Plymouth MN

Chief Executive Officer · signer

Biotech, Plymouth MN

Signed
Named
AmendmentAmendment of an earlier filing
Size is amount sold, up to $30M

Filings

2 filings · 1 offering

May 21, 2026
Equity, signed · Form D
$9.2M
of $10M
May 21, 2026
Latest Jul 1, 2026
Equity
Signed as Chief Executive Officer
$9.2M
$10M
Form D
1 amendmentLatest Jul 1, 2026
- Jul 1, 2026$9.2MForm D
  Jul 1, 2026$9.2MForm D

Network

At Reprise Biomedical

12 people

Alan Woldt
Director
Erwin Kelen
Director
Greg Smock
Executive Officer
Heather Kotila
Executive Officer
Howard Root
Director
Jake Isenburg
Executive Officer

6 more at Reprise Biomedical